Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Trainers' and trainees' expectations of entrustable professional activities (EPAs) in a primary care training programme.

Bonnie LHA, Visser MRM, Bont J, Kramer AWM, van Dijk N.

Educ Prim Care. 2019 Jan;30(1):13-21. doi: 10.1080/14739879.2018.1532773. Epub 2018 Dec 10.

PMID:
30526392
2.

Intervention Descriptions in Medical Education: What Can Be Improved? A Systematic Review and Checklist.

Meinema JG, Buwalda N, van Etten-Jamaludin FS, Visser MRM, van Dijk N.

Acad Med. 2019 Feb;94(2):281-290. doi: 10.1097/ACM.0000000000002428.

4.

Blended learning in CME: the perception of GP trainers.

Te Pas E, Meinema JG, Visser MR, van Dijk N.

Educ Prim Care. 2016 May;27(3):217-24. doi: 10.1080/14739879.2016.1163025. Epub 2016 Mar 25.

PMID:
27012724
5.

Using a retrospective pretest instead of a conventional pretest is replacing biases: a qualitative study of cognitive processes underlying responses to thentest items.

Taminiau-Bloem EF, Schwartz CE, van Zuuren FJ, Koeneman MA, Visser MR, Tishelman C, Koning CC, Sprangers MA.

Qual Life Res. 2016 Jun;25(6):1327-37. doi: 10.1007/s11136-015-1175-4. Epub 2015 Nov 16.

6.

Differential growth in doctor-patient communications skills.

M van Es J, Wieringa-de Waard M, Visser MR.

Med Educ. 2013 Jul;47(7):691-700. doi: 10.1111/medu.12175.

PMID:
23746158
7.

Which barriers affect morbidity registration performance of GP trainees and trainers?

de Jong J, Visser MR, Wieringa-de Waard M.

Int J Med Inform. 2013 Aug;82(8):708-16. doi: 10.1016/j.ijmedinf.2013.02.002. Epub 2013 Feb 28.

PMID:
23453190
8.

Steering the patient mix of GP trainees: results of a randomized controlled intervention.

de Jong J, Visser MR, Wieringa-de Waard M.

Med Teach. 2013;35(2):101-8. doi: 10.3109/0142159X.2013.759197. Epub 2013 Jan 25.

PMID:
23350870
9.

Development of a dry, stable and inhalable acyl-homoserine-lactone-acylase powder formulation for the treatment of pulmonary Pseudomonas aeruginosa infections.

Wahjudi M, Murugappan S, van Merkerk R, Eissens AC, Visser MR, Hinrichs WL, Quax WJ.

Eur J Pharm Sci. 2013 Mar 12;48(4-5):637-43. doi: 10.1016/j.ejps.2012.12.015. Epub 2012 Dec 28.

PMID:
23277289
10.

Two-dimensional structure of the MAAS-Global rating list for consultation skills of doctors.

van Es JM, Schrijver CJ, Oberink RH, Visser MR.

Med Teach. 2012;34(12):e794-9. doi: 10.3109/0142159X.2012.709652. Epub 2012 Sep 3.

PMID:
22938687
11.

SMART, SMARTER, SMARTEST: the influence of peer groups compared to practice visits on the quality of action plans.

van Es JM, Visser MR, Wieringa-De Waard M.

Med Teach. 2012;34(8):e582-8. doi: 10.3109/0142159X.2012.670322. Epub 2012 Apr 11.

PMID:
22494081
12.

Do GP trainers use feedback in drawing up their Personal Development Plans (PDPs)? Results from a quantitative study.

van Es JM, Visser MR, Wieringa-de Waard M.

Med Teach. 2012;34(11):e718-24. doi: 10.3109/0142159X.2012.670327. Epub 2012 Apr 11.

PMID:
22494080
13.

The role of recalibration response shift in explaining bodily pain in cancer patients undergoing invasive surgery: an empirical investigation of the Sprangers and Schwartz model.

Visser MR, Oort FJ, van Lanschot JJ, van der Velden J, Kloek JJ, Gouma DJ, Schwartz CE, Sprangers MA.

Psychooncology. 2013 Mar;22(3):515-22. doi: 10.1002/pon.2114. Epub 2012 Jan 16.

PMID:
22246997
14.

Opening the black box: the patient mix of GP trainees.

de Jong J, Visser MR, Mohrs J, Wieringa-de Waard M.

Br J Gen Pract. 2011 Oct;61(591):e650-7. doi: 10.3399/bjgp11X601361.

15.

Exploring differences in patient mix in a cohort of GP trainees and their trainers.

De Jong J, Visser MR, Wieringa-de Waard M.

BMJ Open. 2011 Nov 14;1(2):e000318. doi: 10.1136/bmjopen-2011-000318. Print 2011.

16.

Opening the black box of cancer patients' quality-of-life change assessments: a think-aloud study examining the cognitive processes underlying responses to transition items.

Taminiau-Bloem EF, Van Zuuren FJ, Visser MR, Tishelman C, Schwartz CE, Koeneman MA, Koning CC, Sprangers MA.

Psychol Health. 2011 Nov;26(11):1414-28. doi: 10.1080/08870446.2011.596203. Epub 2011 Jul 8.

PMID:
21736499
17.

Surface-active derivative of inulin (Inutec® SP1) is a superior carrier for solid dispersions with a high drug load.

Srinarong P, Hämäläinen S, Visser MR, Hinrichs WL, Ketolainen J, Frijlink HW.

J Pharm Sci. 2011 Jun;100(6):2333-42. doi: 10.1002/jps.22471. Epub 2011 Jan 19.

PMID:
21254065
18.

Who determines the patient mix of GP trainees? The role of the receptionist.

de Jong J, Visser MR, Wieringa-de Waard M.

Fam Pract. 2011 Jun;28(3):287-93. doi: 10.1093/fampra/cmq102. Epub 2011 Jan 11.

PMID:
21227900
19.

Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles.

Saluja V, Visser MR, Ter Veer W, van Roosmalen ML, Leenhouts K, Hinrichs WL, Huckriede A, Frijlink HW.

Vaccine. 2010 Nov 23;28(50):7963-9. doi: 10.1016/j.vaccine.2010.09.066. Epub 2010 Oct 12.

PMID:
20946860
20.

Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.

Srinarong P, Kouwen S, Visser MR, Hinrichs WL, Frijlink HW.

Pharm Dev Technol. 2010 Sep-Oct;15(5):460-8. doi: 10.3109/10837450903286529.

PMID:
20735300
21.

Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with Gram-positive enhancer matrix (GEM) particles.

Saluja V, Visser MR, van Roosmalen ML, Leenhouts K, Huckriede A, Hinrichs WL, Frijlink HW.

Eur J Pharm Biopharm. 2010 Nov;76(3):470-4. doi: 10.1016/j.ejpb.2010.08.003. Epub 2010 Aug 16.

PMID:
20719246
22.

A 'short walk' is longer before radiotherapy than afterwards: a qualitative study questioning the baseline and follow-up design.

Taminiau-Bloem EF, van Zuuren FJ, Koeneman MA, Rapkin BD, Visser MR, Koning CC, Sprangers MA.

Health Qual Life Outcomes. 2010 Jul 16;8:69. doi: 10.1186/1477-7525-8-69.

23.

Somatically ill persons' self-nominated quality of life domains: review of the literature and guidelines for future studies.

Taminiau-Bloem EF, Visser MR, Tishelman C, Koeneman MA, van Zuuren FJ, Sprangers MA.

Qual Life Res. 2010 Mar;19(2):253-91. doi: 10.1007/s11136-009-9569-9. Epub 2010 Jan 3. Review.

24.

Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240.

Visser MR, Baert L, Klooster Gv, Schueller L, Geldof M, Vanwelkenhuysen I, de Kock H, De Meyer S, Frijlink HW, Rosier J, Hinrichs WL.

Eur J Pharm Biopharm. 2010 Feb;74(2):233-8. doi: 10.1016/j.ejpb.2009.10.004. Epub 2009 Oct 25.

PMID:
19861163
25.

Structural equation modeling of health-related quality-of-life data illustrates the measurement and conceptual perspectives on response shift.

King-Kallimanis BL, Oort FJ, Visser MR, Sprangers MA.

J Clin Epidemiol. 2009 Nov;62(11):1157-64. doi: 10.1016/j.jclinepi.2009.04.004.

PMID:
19595574
26.

Formal definitions of measurement bias and explanation bias clarify measurement and conceptual perspectives on response shift.

Oort FJ, Visser MR, Sprangers MA.

J Clin Epidemiol. 2009 Nov;62(11):1126-37. doi: 10.1016/j.jclinepi.2009.03.013. Epub 2009 Jun 21.

PMID:
19540722
27.

Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants.

Srinarong P, Faber JH, Visser MR, Hinrichs WL, Frijlink HW.

Eur J Pharm Biopharm. 2009 Sep;73(1):154-61. doi: 10.1016/j.ejpb.2009.05.006. Epub 2009 May 22.

PMID:
19465121
28.

Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine.

Kerckhoffs AP, Visser MR, Samsom M, van der Rest ME, de Vogel J, Harmsen W, Akkermans LM.

J Clin Gastroenterol. 2008 Nov-Dec;42(10):1095-102. doi: 10.1097/MCG.0b013e31818474d7.

PMID:
18936644
29.

Clarifying quality of life assessment: do theoretical models capture the underlying cognitive processes?

Bloem EF, van Zuuren FJ, Koeneman MA, Rapkin BD, Visser MR, Koning CC, Sprangers MA.

Qual Life Res. 2008 Oct;17(8):1093-102. doi: 10.1007/s11136-008-9380-z. Epub 2008 Aug 14.

PMID:
18704756
30.

Timing of surgical intervention in necrotizing pancreatitis.

Besselink MG, Verwer TJ, Schoenmaeckers EJ, Buskens E, Ridwan BU, Visser MR, Nieuwenhuijs VB, Gooszen HG.

Arch Surg. 2007 Dec;142(12):1194-201.

PMID:
18086987
31.

Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated.

de Waard H, Hinrichs WL, Visser MR, Bologna C, Frijlink HW.

Int J Pharm. 2008 Feb 12;349(1-2):66-73. Epub 2007 Jul 24.

PMID:
17804180
32.

The use of animal models to study bacterial translocation during acute pancreatitis.

van Minnen LP, Blom M, Timmerman HM, Visser MR, Gooszen HG, Akkermans LM.

J Gastrointest Surg. 2007 May;11(5):682-9. Epub 2007 Mar 7. Review.

33.

Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis.

van Minnen LP, Timmerman HM, Lutgendorff F, Verheem A, Harmsen W, Konstantinov SR, Smidt H, Visser MR, Rijkers GT, Gooszen HG, Akkermans LM.

Surgery. 2007 Apr;141(4):470-80. Epub 2007 Jan 25.

PMID:
17383524
34.

Hirschsprung's disease: healthcare meets the needs.

Hartman EE, Sprangers MA, Visser MR, Oort FJ, Hanneman MJ, van Heurn LW, de Langen ZJ, Madern GC, Rieu PN, van der Zee DC, van Silfhout-Bezemer M, Aronson DC.

J Pediatr Surg. 2006 Aug;41(8):1420-4.

PMID:
16863848
35.

The use of Stokes deformation number as a predictive tool for material exchange behaviour of granules in the 'equilibrium phase' in high shear granulation.

Bouwman AM, Visser MR, Meesters GM, Frijlink HW.

Int J Pharm. 2006 Aug 2;318(1-2):78-85. Epub 2006 Apr 1.

PMID:
16713144
36.

Quality of life in newly diagnosed cancer patients waiting for surgery is seriously impaired.

Visser MR, van Lanschot JJ, van der Velden J, Kloek JJ, Gouma DJ, Sprangers MA.

J Surg Oncol. 2006 Jun 1;93(7):571-7.

PMID:
16705725
37.
38.

Effects of subtotal colectomy on bacterial translocation during experimental acute pancreatitis.

van Minnen LP, Nieuwenhuijs VB, de Bruijn MT, Verheem A, Visser MR, van Dijk JE, Akkermans LM, Gooszen HG.

Pancreas. 2006 Jan;32(1):110-4.

PMID:
16340752
39.

Explaining change over time in quality of life of adult patients with anorectal malformations or Hirschsprung's disease.

Hartman EE, Oort FJ, Visser MR, Sprangers MA, Hanneman MJ, de Langen ZJ, va Heurn LW, Rieu PN, Madern GC, van der Zee DC, Looyard N, van Silfhout-Bezemer M, Aronson DC.

Dis Colon Rectum. 2006 Jan;49(1):96-103.

PMID:
16328611
40.

Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.

van Drooge DJ, Hinrichs WL, Dickhoff BH, Elli MN, Visser MR, Zijlstra GS, Frijlink HW.

Eur J Pharm Sci. 2005 Oct;26(2):231-40.

PMID:
16084699
41.

Anorectal malformations: does healthcare meet the needs?

Hartman EE, Sprangers MA, Visser MR, Oort FJ, Hanneman MJ, van Heurn LW, de Langen ZJ, Madern GC, Rieu PN, van der Zee DC, Looyaard N, Aronson DC.

J Pediatr Gastroenterol Nutr. 2005 Aug;41(2):210-5.

PMID:
16056101
42.

Methods to detect response shift in quality of life data: a convergent validity study.

Visser MR, Oort FJ, Sprangers MA.

Qual Life Res. 2005 Apr;14(3):629-39.

PMID:
16022057
44.

The effect of vessel material on granules produced in a high-shear mixer.

Bouwman AM, Visser MR, Eissens AC, Wesselingh JA, Frijlink HW.

Eur J Pharm Sci. 2004 Oct;23(2):169-79.

PMID:
15451005
45.

Quality of life after colon interposition by necessity for esophageal cancer replacement.

Cense HA, Visser MR, van Sandick JW, de Boer AG, Lamme B, Obertop H, van Lanschot JJ.

J Surg Oncol. 2004 Oct 1;88(1):32-38.

PMID:
15384087
46.

Solid dispersions based on inulin for the stabilisation and formulation of delta 9-tetrahydrocannabinol.

van Drooge DJ, Hinrichs WL, Wegman KA, Visser MR, Eissens AC, Frijlink HW.

Eur J Pharm Sci. 2004 Mar;21(4):511-8.

PMID:
14998582
47.

The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life.

Van Heek NT, De Castro SM, van Eijck CH, van Geenen RC, Hesselink EJ, Breslau PJ, Tran TC, Kazemier G, Visser MR, Busch OR, Obertop H, Gouma DJ.

Ann Surg. 2003 Dec;238(6):894-902; discussion 902-5.

48.

Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis.

Van Felius ID, Akkermans LM, Bosscha K, Verheem A, Harmsen W, Visser MR, Gooszen HG.

Neurogastroenterol Motil. 2003 Jun;15(3):267-76.

PMID:
12787336
49.

Stress, satisfaction and burnout among Dutch medical specialists.

Visser MR, Smets EM, Oort FJ, De Haes HC.

CMAJ. 2003 Feb 4;168(3):271-5.

50.

Sex differences in physician burnout in the United States and The Netherlands.

Linzer M, McMurray JE, Visser MR, Oort FJ, Smets E, de Haes HC.

J Am Med Womens Assoc (1972). 2002 Fall;57(4):191-3.

PMID:
12405233

Supplemental Content

Loading ...
Support Center